These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22006035)

  • 41. Assessment of systolic dyssynchrony for cardiac resynchronization therapy is not clinically useful.
    Sung RK; Foster E
    Circulation; 2011 Feb; 123(6):656-62. PubMed ID: 21321181
    [No Abstract]   [Full Text] [Related]  

  • 42. "Underestimation" of a left ventricular threshold.
    Ploux S; Thambo JB; Bordachar P
    Arch Cardiovasc Dis; 2011 Nov; 104(11):591-2. PubMed ID: 22117912
    [No Abstract]   [Full Text] [Related]  

  • 43. Mechanical dyssynchrony in congestive heart failure: diagnostic and therapeutic implications.
    Nagueh SF
    J Am Coll Cardiol; 2008 Jan; 51(1):18-22. PubMed ID: 18174031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prognostic role of right ventricular function in left ventricular disease in the setting of cardiac resynchronization therapy.
    Abdirahman I; Haddad T; Dwivedi G
    Curr Opin Cardiol; 2014 Mar; 29(2):185-91. PubMed ID: 24406447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction.
    Bertini M; Ziacchi M; Biffi M; Biagini E; Rocchi G; Martignani C; Ferlito M; Pasquale F; Cervi E; Branzi A; Rapezzi C; Boriani G
    Heart; 2011 Feb; 97(4):295-300. PubMed ID: 21163889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
    Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR;
    Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac resynchronization therapy or atrio-biventricular pacing-what should it be called?
    Cleland JG; Nasir M; Tageldien A
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4(2):90-101. PubMed ID: 17245403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Left ventricular dyssynchrony in patients with heart failure: pathophysiology, diagnosis and treatment.
    Bleeker GB; Bax JJ; Steendijk P; Schalij MJ; van der Wall EE
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):213-9. PubMed ID: 16568130
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiogenic shock shortly after initial success of cardiac resynchronization therapy.
    Kanhai SM; Viergever EP; Bax JJ
    Eur J Heart Fail; 2004 Jun; 6(4):477-81. PubMed ID: 15182774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of cardiac resynchronization therapy in asymptomatic and mildly symptomatic heart failure.
    Forcina MS; Gold MR
    Curr Heart Fail Rep; 2009 Mar; 6(1):44-8. PubMed ID: 19265592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac resynchronisation therapy in patients with chronic heart failure.
    Lalani GG; Birgersdotter-Green U
    Heart; 2015 Jul; 101(13):1008-14. PubMed ID: 25882504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel approach for heart failure treatment after liver transplantation.
    Moguilevitch M; Rufino M; Leff J; Delphin E
    Liver Transpl; 2015 Aug; 21(8):1103-4. PubMed ID: 26069158
    [No Abstract]   [Full Text] [Related]  

  • 53. Summaries for patients: management of chronic heart failure in adults: guidelines from the National Institute For Health and clinical excellence.
    Ann Intern Med; 2011 Aug; 155(4):I-42. PubMed ID: 21844534
    [No Abstract]   [Full Text] [Related]  

  • 54. Left ventricular endocardial leadless pacing brings new hope to patients with heart failure.
    Wang HX; Li XF; Zhang H; Sun S
    Int J Cardiol; 2013 Aug; 167(3):1073-4. PubMed ID: 23168008
    [No Abstract]   [Full Text] [Related]  

  • 55. Assessment of systolic dyssynchrony for cardiac resynchronization therapy is clinically useful.
    Delgado V; Bax JJ
    Circulation; 2011 Feb; 123(6):640-55. PubMed ID: 21321180
    [No Abstract]   [Full Text] [Related]  

  • 56. [Device therapy in chronic heart failure].
    Schaer BA; Sticherling C
    Ther Umsch; 2011 Feb; 68(2):89-93. PubMed ID: 21271539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relation between severity of left ventricular systolic dysfunction and repolarisation abnormalities on the surface ECG: a report from the Euro heart failure survey.
    Velavan P; Khan NK; Rigby AS; Goode K; Komajda M; Follath F; Swedberg K; Madeira H; Clark AL; Cleland JG
    Heart; 2006 Feb; 92(2):255-6. PubMed ID: 16415196
    [No Abstract]   [Full Text] [Related]  

  • 58. Reversing heart failure by CRT: how long do the effects last?
    Breithardt OA
    Eur Heart J; 2013 Sep; 34(33):2582-4. PubMed ID: 23832489
    [No Abstract]   [Full Text] [Related]  

  • 59. A comparison of long-term outcomes between narrow and broad QRS complex patients treated with cardiac resynchronization therapy.
    Yap LB; Nguyen ST; Qadir F; Ma SK; Muhammad Z; Koh KW; Ali Z; Tay GS; Daud A; Said A; Sahat N; Rebo R; Tamin SS; Hussin A; Kaur S; Omar R
    Acta Cardiol; 2016 Jun; 71(3):323-30. PubMed ID: 27594128
    [No Abstract]   [Full Text] [Related]  

  • 60. Electrical remodeling after cardiac resynchronization therapy and its relationship with the anatomical remodeling.
    D'Onofrio A; Iuliano A; De Simone A; Pecora D; Rapacciuolo A; Ricciardi G; Marini M; Pepi P; Caico SI; Palmisano P; Giovannini T; Arena G; Maglia G; Ospizio R; Botto GL; Bertaglia E; Stabile G
    Int J Cardiol; 2016 May; 211():86-7. PubMed ID: 26991554
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.